The latest ACSH health headlines: The HPV vaccines works! And the U.S. has some catching up to do. What's bugging New Yorkers? Bed bugs of course, and ACSH's Dr. Josh Bloom's take on the matter appears in the Wall Street Journal. And yet another study showing the dangers of using herbal and dietary supplements- this time, liver damage.
The HPV vaccine is one of two vaccines in existence that prevent cancer, yet only 38 percent of adolescent girls and 14 percent of adolescent boys have received all three doses of this vaccine. ACSH trustee Dr. Paul Offit
HPV, the most common sexually transmitted infection, can lead to several types of cancers, including cervical. About 79 million Americans are currently infected with HPV, and there are about 14 million new cases every year.
Yesterday, the New York City Health Department launched a campaign promoting the benefits of the HPV vaccine in an effort to encourage parents to vaccinate their children. HPV is the most common sexually
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. For this reason, it is recommended that adolescents, both
A new study conducted by the National Institutes of health s National Cancer Institute has found that negative tests for the human papillomavirus virus (HPV) are more reliable in predicting
As we reported last month, an advisory panel to the FDA recommended that the agency approve a new test for human papillomavirus (HPV) for screening women for cervical cancer. The new test could potentially replace the current Pap test that has been in use for decades.
The United States is trailing the rest of the world in terms of HPV vaccination rates. As we have written recently, according to the CDC, vaccination rates among girls are only at 33 percent. The rate among
Human papillomavirus (HPV) is a leading cause of cervical cancer in women and genital warts in both sexes. Fortunately, these ills can now be prevented by a series of vaccinations that are typically given before a boy or girl becomes sexually active.
ACSH applauds the commonsense response of the American Board of Ob-Gyn in reversing their counterproductive stance on allowing their members to deal with male patients. It takes guts to admit error, and the Board members deserve our admiration.
Two pieces of good news regarding protecting from, and detecting early, cervical cancer caused by HPV: one dose of vaccine may work as well as the recommended three; and screening cervical cells for HPV may be more predictive of dangerous infection than the Pap smear.